Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Helfer

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Waste Management (New York, N.Y.)|June 20, 2025
Detection of degraded high-density polyethylene via near-infrared hyperspectral imagingJ Geier, C Barretta, M Messiha, et al.
Clinical Pediatrics|September 1, 1971
White House Conference on Children. Personal reflectionsA F North, R E Helfer, J Spurlock, et al.
Clinical Pharmacokinetics|July 2, 2024
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric PopulationFernando O Carreño, Jacqueline G Gerhart, Victória E Helfer, et al.
Antimicrobial Agents and Chemotherapy|May 3, 2017
Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar RatsBruna G S Torres, Victória E Helfer, Priscila M Bernardes, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 5, 2024
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric populationElizabeth J Thompson, Angela Jeong, Victória E Helfer, et al.
Clinical Pharmacokinetics|May 16, 2025
Exploring the Influence of Obesity and CYP2 C19 Genotype on Lansoprazole Pharmacokinetics in Pediatric Patients: A Population Modeling ApproachVictória E Helfer, Daniel Gonzalez, Kathryn E Kyler, et al.
Journal of Clinical Pharmacology|March 28, 2024
Using Real-World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and InfantsSean McCann, Victória E Helfer, Stephen J Balevic, et al.
Clinical and Translational Science|May 14, 2025
Physiologically Based and Population Pharmacokinetic Modeling of Midazolam in Children With Obesity Using Real-World DataSean McCann, Victória E Helfer, Stephen J Balevic, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 12, 2026
External Pharmacokinetic Model Evaluation of Caffeine in Critically Ill Neonates With Heart Disease Using Data Collected From a Pragmatic Platform TrialCourtney Hallock, Annalisa Hawk, Calla Castro, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Waste Management (New York, N.Y.)|June 20, 2025
Detection of degraded high-density polyethylene via near-infrared hyperspectral imagingJ Geier, C Barretta, M Messiha, et al.
Clinical Pediatrics|September 1, 1971
White House Conference on Children. Personal reflectionsA F North, R E Helfer, J Spurlock, et al.
Clinical Pharmacokinetics|July 2, 2024
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric PopulationFernando O Carreño, Jacqueline G Gerhart, Victória E Helfer, et al.
Antimicrobial Agents and Chemotherapy|May 3, 2017
Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar RatsBruna G S Torres, Victória E Helfer, Priscila M Bernardes, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 5, 2024
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric populationElizabeth J Thompson, Angela Jeong, Victória E Helfer, et al.
Clinical Pharmacokinetics|May 16, 2025
Exploring the Influence of Obesity and CYP2 C19 Genotype on Lansoprazole Pharmacokinetics in Pediatric Patients: A Population Modeling ApproachVictória E Helfer, Daniel Gonzalez, Kathryn E Kyler, et al.
Journal of Clinical Pharmacology|March 28, 2024
Using Real-World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and InfantsSean McCann, Victória E Helfer, Stephen J Balevic, et al.
Clinical and Translational Science|May 14, 2025
Physiologically Based and Population Pharmacokinetic Modeling of Midazolam in Children With Obesity Using Real-World DataSean McCann, Victória E Helfer, Stephen J Balevic, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 12, 2026
External Pharmacokinetic Model Evaluation of Caffeine in Critically Ill Neonates With Heart Disease Using Data Collected From a Pragmatic Platform TrialCourtney Hallock, Annalisa Hawk, Calla Castro, et al.
Pageof 5